Arimoclomol, a heat shock protein-based therapy, shows promise for the treatment of amyotrophic lateral sclerosis, or ALS, based on the results of a phase II trial initiated and led by Michael Benatar, M.D., Ph.D., professor of neurology at the University of Miami Miller School of Medicine. The study showed the drug is safe and well tolerated, with preliminary evidence of efficacy.
AAN2017 Alumni Reception Boston - 4/25/17
NeuroUpdate Feb 9-11, 2017Register Now
Moving Day 2016More Info
ALS Team Accepts Ice Bucket Challenge
The University of Miami hosted its first Neural Engineering Symposium on October 13 to promote collaborations among research, educational, and industry programs for this rapidly growing discipline. Ozcan Ozdamar, Ph.D., professor and chair of the College of Engineering’s Department of Biomedical Engineering, and W. Dalton Dietrich, Ph.D., Scientific Director of The Miami Project to Cure Paralysis were Co-Directors.
The Miller School of Medicine Department of Neurology’s American Stroke Association-Bugher Center of Excellence in Stroke Collaborative Research hosted the 2016 Annual Bugher Center of Excellence Meeting October 20 and 21. The event celebrated the center’s third year of funding from the Henrietta B. and Frederick H. Bugher Foundation.